Literature DB >> 7057400

Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.

P Bianchini, B Osima, B Parma, H B Nader, C P Dietrich.   

Abstract

The pharmacological activities of 14 heparins prepared from bovine and hog tissues and heparin fractions obtained by molecular sieving on sephacryl S-200 and antithrombin III affinity chromatography are reported. Two groups of heparins can be distinguished regarding the lipoprotein lipase releasing activity (LPL) and the activated partial thromboplastin time (APTT). Heparins prepared from liver, lung, pancreas and thymus have a ratio of LPL/APTT of 3.6, whereas heparins prepared from placenta and intestine show a ratio of only 2.1. The heparin APTT, LPL, antihemolytic, antifactor Xa and anticoagulant activities were partially resolved by fractionation on Sephacryl S-200 chromatography and antithrombin III affinity chromatography. These results suggest the presence of a mixture of heparins with different pharmacological activities in a commercial preparation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057400

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma.

Authors:  A Klein; S Ramcharitar; N Christeff; E Nisbett-Brown; E Nunez; A Malkin
Journal:  In Vitro Cell Dev Biol       Date:  1991-04

Review 2.  Low molecular weight heparins. An objective overview.

Authors:  D Hoppensteadt; J M Walenga; J Fareed
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

3.  Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Authors:  Jung-hyun Rho; Shuzhen Qin; Julia Y Wang; Michael H A Roehrl
Journal:  J Proteome Res       Date:  2008-06-13       Impact factor: 4.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.